What is Absci Corp (ABSI) stock price today?

Absci Corp (ABSI) currently trades at $4.71 per share. The stock has a market capitalization of $732.16M and a P/E ratio of —x.

Is ABSI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Absci Corp has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -1.55.

What is Absci Corp's revenue and earnings?

Absci Corp has trailing twelve-month (TTM) revenue of $2.80M with profit margins of 0.00%. Earnings per share (EPS) is $-0.84.

Is Absci Corp financially healthy?

Absci Corp's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -1.55 places it in the distress.

ABSI

Absci Corp

NASDAQ: ABSI · HEALTHCARE · BIOTECHNOLOGY

$4.71

-3.09% today

Updated 2026-04-29

Market cap

$732.16M

P/E ratio

—

P/S ratio

261.48x

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$2 – $5

Volume

4.1M

Market cap

$732.16M

P/E ratio

—

P/S ratio

261.48x

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$2 – $5

Volume

4.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

7.0

Quality

B+

2.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-1.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.03

+70.49%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.03x — low leverage

Risks

- Altman Z -1.55 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-29.29M

- Revenue declining -2.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$5.75M	$5.72M	$4.53M	$2.80M	$2.80M
Net income	$-104.90M	$-110.57M	$-103.11M	$-115.18M	$-29.56M
EPS	—	—	—	—	$-0.84
Free cash flow	$-97.51M	$-65.50M	$-72.81M	$-94.03M	$-29.29M
Profit margin	-1,825.37%	-1,933.65%	-2,274.06%	-4,113.68%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-12	BUSCH, ANDREAS	Buy	100,000	$2.29
2026-03-03	WALKER, SHELBY J.	Sale	9,825	$2.80
2026-03-03	MCCLAIN, SEAN	Sale	25,316	$2.80

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ABSI	$732.16M	23	2.7	2.5	5.0	7.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Absci Corp trades at $4.71. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -1.55, it sits in the distress. TTM revenue stands at $2.80M.

Frequently asked questions

What is Absci Corp's stock price?

Absci Corp (ABSI) trades at $4.71.

Is Absci Corp overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Absci Corp (ABSI)?

The analyst target price is $8.03, representing +70.5% upside from the current price of $4.71.

What is Absci Corp's revenue?

TTM revenue is $2.80M.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-1.55 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.absci.com

Quick metrics

P/S ratio261.48x

ROE-62.50%

Beta2.01

50D MA$3.06

200D MA$3.17

Shares out0.16B

Float0.14B

Short ratio—

Avg volume4.1M

Performance

1 week+24.36%

1 month+74.46%

3 months+62.75%

YTD+38.97%

1 year—

3 years—

5 years—

Compare

ABSI vs LLY →ABSI vs JNJ →ABSI vs ABBV →Stock screener →